In recent years, daily low-dose ketamine has gained recognition as a promising option within the broader landscape of mental health support, particularly for anxiety, depression, and treatment-resistant depression (TRD). As a company providing at-home ketamine treatments, we’re focused on making this therapeutic tool more accessible, safe, and carefully guided—while also helping to clear up common misunderstandings. With millions of Americans struggling to find relief through traditional treatments, ketamine therapy offers new hope—but it’s also often misunderstood and stigmatized. We believe education and responsible use are key to ensuring its benefits are understood and respected.
One of the most common misunderstandings about ketamine is the difference between its therapeutic use and non-medical use. Responsible, medically-guided use—like the low-dose protocols we offer at Joyous—can play a valuable role in mental health care. However, when ketamine is taken without appropriate structure or oversight, its benefits can be misunderstood or diminished. That’s why education, proper support, and clear boundaries are so important to ensure it’s used safely and effectively.
Ketamine is classified as a schedule III non-narcotic nonbarbiturate dissociative anesthetic. Schedule III medications are defined as having low to moderate potential for physical and psychological dependence. Other schedule III medications with a similar additional potential include anabolic steroids and testosterone.
When used responsibly and with the right structure, ketamine treatment can be a valuable component of mental wellness, as supported by our own patient data where over 89% of patients report improved anxiety and depression symptoms in their first month of treatment. Our treatment uses low-dose ketamine lozenges (troches) with approximately 25% bioavailability, designed to dissolve slowly in the cheek. Each dose is delivered as part of a structured, at-home treatment plan with medical supervision. Each patient receives personalized medical care from licensed providers, ensuring that treatment is tailored to their unique needs and mental health goals. Dosing is carefully regulated, with protocols in place to monitor progress and adjust as needed. Unlike traditional antidepressants, we gather real-time patient data on a daily basis, tracking how they’re feeling, how the medication is affecting them, any side effects they may experience, and adjusting their dosage based on this feedback. This combination of medical oversight, structure, and accessibility helps people engage with ketamine therapy in a safe, consistent, and empowering way.
By contrast, recreational ketamine use typically lacks structure, guidance, and intention, and the substance itself is unregulated and typically comes in powder form which has a much higher bioavailability than our treatment. High doses taken without medical support are not safe or recommended, and they don't reflect the careful, therapeutic use we advocate. This often raises the question: is ketamine addictive when used for depression? In the context of medically-supported, low-dose protocols, when taken as prescribed, the risk is low. The key difference lies in how ketamine is used, in what form, and under what medical supervision—all of which significantly affect its safety and effectiveness.
While many experts emphasize the importance of medical supervision with ketamine treatment for psychiatric or mental health conditions, the primary concerns around at-home use typically center on two risks: patients experiencing intense dissociation from high doses and the potential for misuse, especially when ketamine is prescribed in large quantities or in highly bioavailable forms like injectable solutions or high-dose lozenges.
At Joyous, our program was specifically designed to minimize these risks, with patient safety and treatment efficacy as our highest priorities.
Unlike many at-home ketamine providers, Joyous uses very low doses—known as psycholytic or microdoses—that allow patients to remain fully oriented, self-aware, and engaged with their environment during sessions. In addition, our waxy lozenge is intentionally designed to dissolve slowly over ~15 minutes when placed in the cheek, which both moderates absorption and makes it difficult to take more than the prescribed dose without compromising effectiveness.
To further support safety, our providers use AI-powered monitoring tools and medication tracking to stay informed of each patient’s symptom patterns, side effects, and response to treatment—ensuring that care remains personalized and adaptive over time.
Recent media stories have brought increased attention to ketamine and its role in treating mental health. From researchers like Andrew Hubermann, to self-help personalities like Tim Ferris and alternative health advocates like Michael Pollan, ketamine treatment has been highlighted in recent years for its potential positive impact for patients experiencing depression and anxiety, and the shifting perception of this alternative treatment. These conversations along with the research being done across the country have helped spark public dialogue, and also underscore the importance of respecting this substance and taking part in treatment responsibly, with medical oversight and safety protocols like those built into the Joyous treatment.
At Joyous, we believe in responsible, evidence-based use of low dose ketamine treatment for mental health conditions. We're committed to reducing the stigma by clearly distinguishing between therapeutic treatment and recreational misuse. When used correctly, ketamine treatment can be a tool for healing and therapeutic skillbuilding with benefits that can last far beyond treatment.
By sharing real stories and our commitment to safe practices, we aim to promote informed, respectful conversations around ketamine and its role in mental health care. Our mission is to empower individuals with accurate information and compassionate care.
Ketamine, like any powerful medication, carries both potential and risk. Whether someone is exploring low dose ketamine treatment for anxiety or asking, “Is ketamine addictive when used for depression?”—the answer lies in context and medical oversight.
Daily ketamine use without supervision raises significant concerns, while carefully monitored, short-term treatments can be life-changing. Let's continue to treat this emerging therapy with the respect it deserves, guided by science, safety, and empathy.